Seres Therapeutics, Inc. (1S9.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 04:00PM CEST
| Previous Close | 1.1855 |
| Open | 1.2310 |
| Bid | 1.2105 x 30000 |
| Ask | 1.2580 x 30000 |
| Day's Range | 1.2310 - 1.2635 |
| 52 Week Range | 0.5302 - 4.6400 |
| Volume | |
| Avg. Volume | 506 |
| Market Cap | 202.53M |
| Beta (5Y Monthly) | 1.96 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Even after rising 29% this past week, Seres Therapeutics (NASDAQ:MCRB) shareholders are still down 84% over the past three years
Seres Therapeutics, Inc. ( NASDAQ:MCRB ) shareholders will doubtless be very grateful to see the share price up 125% in...
- Insider Monkey
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2024 Earnings Call Transcript
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2024 Earnings Call Transcript May 11, 2024 Seres Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. My name is Alex, and I will be your conference operator today. […]
- Simply Wall St.
Seres Therapeutics First Quarter 2024 Earnings: US$0.28 loss per share (vs US$0.56 loss in 1Q 2023)
Seres Therapeutics ( NASDAQ:MCRB ) First Quarter 2024 Results Key Financial Results Net loss: US$40.1m (loss narrowed...
© 2024 Yahoo. All rights reserved.